Sign in

CIK 0001831915 · Accelerated filer

Cytek Biosciences, Inc.

Sign in to watch
Ticker
CTKB
Exchange
Nasdaq
Industry
Laboratory Analytical Instruments
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
472547526
Phone
(877) 922-9835
Business address
47215 LAKEVIEW BOULEVARD, FREMONT, CA, 94538
  1. 4 Planned sale Chief Financial Officer sold 3,000 shares at $4.68 ($14,040)
  2. 4 Open-market sale Chief Technology Officer sold 20,000 shares at $4.80 ($96,000)
  3. 4 Planned sale President and CEO sold 20,000 shares at $5.33 ($106,600)
  4. 4 Gift President and CEO gave 2,290,000 shares (gift)
  5. 4 Planned sale Chief Financial Officer sold 3,000 shares at $6.38 ($19,140)
  6. 4 Open-market sale Chief Technology Officer sold 20,000 shares at $6.49 ($129,800)
  7. 4 Open-market sale President and CEO sold 20,000 shares at $6.83 ($136,600)
  8. 3 Insider Initial Statement of Ownership
  9. 4 Planned sale Chief Financial Officer sold 3,000 shares at $7.69 ($23,070)
  10. 4 Shares withheld for taxes Chief Financial Officer gave up 2,117 shares (to pay taxes)
  11. 4 Shares withheld for taxes President and CEO gave up 6,210 shares (to pay taxes)
  12. 4 Shares withheld for taxes Chief Operating Officer gave up 359 shares (to pay taxes)
  13. 4 Shares withheld for taxes General Counsel gave up 2,220 shares (to pay taxes)
  14. 4 Shares withheld for taxes SVP Bus. and Corp. Dev. gave up 1,283 shares (to pay taxes)
  15. 4 Shares withheld for taxes Chief Commercial Officer gave up 1,836 shares (to pay taxes)
  16. 4 Planned sale Chief Technology Officer sold 20,000 shares at $8.07 ($161,400)
  17. 4 Open-market sale President and CEO sold 20,000 shares at $9.04 ($180,800)
  18. 4 Planned sale Chief Financial Officer sold 3,000 shares at $9.17 ($27,510)
  19. 4 Planned sale Chief Technology Officer sold 20,000 shares at $8.76 ($175,200)
  20. 4 Planned sale President and CEO sold 20,000 shares at $8.48 ($169,600)

Page 8 of 15 · 295 filings